In addition, the suppression of ALS behavioral defects in a C. elegans model by increasing PLS3 or decreasing SYM-2 expression shows that conserved pathways are affected across motor neuron diseases. This evidence concerns the gene PLS3 and amyotrophic lateral sclerosis.